Elligo Health Research announced the launch of its expanded System of Accelerated Research (SOAR) model for decentralized and hybrid trial models.
According to a press release, the platform offers full remote monitoring.
“We are extremely excited to launch our tech-enabled solution created to keep the patient and the physician at the heart of its design, while providing sponsors transparency,” Elligo CEO John Potthoff said in a statement. “Our goal has always been to provide all patients with access to research as a healthcare option, which is important now more than ever as we navigate the future of clinical research.”
To read the full press release, click here.
